Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Stephanie G. Lee"'
Autor:
Stephanie G. Lee, John Fralick, Christopher J. D. Wallis, Monica Boctor, Michelle Sholzberg, Michael Fralick
Publikováno v:
European journal of haematologyREFERENCES. 108(6)
To conduct a systematic review of tranexamic acid (TXA) and the risk of renal failure from urinary clots in adult patients with hematuria.A systematic review of Medline, Embase, CENTRAL, www.gov, and Google Scholar were searched. Randomized control t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe6b86934ccc0f417c4d527eb06381de
https://pubmed.ncbi.nlm.nih.gov/35266205
https://pubmed.ncbi.nlm.nih.gov/35266205
Autor:
Lisa Baumann Kreuziger, Grace H. Tang, Michelle Sholzberg, Michael Fralick, Brandon Tse, Stephanie G. Lee, Peter Jüni, Mary Cushman
BackgroundUnderstanding the association between Coronavirus Disease 2019 (COVID-19) and coagulopathy may assist clinical prognostication, and influence treatment and outcomes. We aimed to systematically describe the relationship between hemostatic la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a188d8fbc441772b670391baa7750b2f
https://doi.org/10.1101/2021.01.05.20248202
https://doi.org/10.1101/2021.01.05.20248202
Publikováno v:
CMAJ
Coagulopathy correlates with severity of COVID-19 and may include increased d-dimer concentrations (≥ 2 times above normal range), mildly prolonged prothrombin time (~ 1–3 s prolongation above normal range), mild thrombocytopenia (platelet count
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f7e4e35af45e82ecc0d072f1eb1913a
https://pubmed.ncbi.nlm.nih.gov/32357997
https://pubmed.ncbi.nlm.nih.gov/32357997
Publikováno v:
CMAJ
La coagulopathie est en correlation avec la gravite de la COVID-19 et pourrait inclure des concentrations elevees de d-dimeres (≥ 2 fois la limite superieure de la normale), un temps de prothrombine legerement prolonge (~ 1–3 s par rapport a la n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83217c2d4dfb83e6d7e10b56ab94f9c3
https://doi.org/10.1503/cmaj.200685-f
https://doi.org/10.1503/cmaj.200685-f
Publikováno v:
Blood. 128:5992-5992
Background: Hodgkin lymphoma (HL) and aggressive non-Hodgkin lymphoma (NHL) both have relatively high curative-potential with contemporary treatment strategies. Despite this, a substantial number of patients will relapse, and a principal objective of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c79251461a25b42d743cc171dee4c2b
https://doi.org/10.1182/blood.v128.22.5992.5992
https://doi.org/10.1182/blood.v128.22.5992.5992